Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B

Meng Taing, Yen Fang Keng, Kui Shen, Li Wu, David S. Lawrence, Zhong Yin Zhang

Research output: Contribution to journalArticle

Abstract

Several protein tyrosine phosphatases (PTPases) have been implicated as regulatory agents in the insulin-stimulated signal transduction pathway, including PTP1B, PTPα, and LAR. Furthermore, since all three enzymes are suggested to serve as negative regulators of insulin signaling, one or more may play a pivotal role in the pathogenesis of insulin resistance. We report herein the acquisition of highly selective PTP1B-targeted inhibitors. We recently demonstrated that PTP1B contains two proximal aromatic phosphate binding sites [Puius, Y. A., Zhao, Y., Sullivan, M., Lawrence, D. S., Almo S. C., and Zhang, Z. Y. (1997) Proc. Natl. Acad. Sci. U.S.A. 94, 13420-5], and we have now employed this structural feature to design and synthesize an array of bis(aryldifluorophosphonates). Not only do the lead compounds serve as potent inhibitors of PTP1B but, in addition, several exhibit selectivities for PTP1B versus PTPα, LAR, and VHR that are greater than 2 orders in magnitude.

Original languageEnglish (US)
Pages (from-to)3793-3803
Number of pages11
JournalBiochemistry®
Volume38
Issue number12
DOIs
StatePublished - Mar 23 1999
Externally publishedYes

Fingerprint

Non-Receptor Type 1 Protein Tyrosine Phosphatase
Insulin
Protein Tyrosine Phosphatases
Lead compounds
Insulin Resistance
Signal Transduction
Signal transduction
Phosphates
Binding Sites
Enzymes

ASJC Scopus subject areas

  • Biochemistry

Cite this

Taing, M., Keng, Y. F., Shen, K., Wu, L., Lawrence, D. S., & Zhang, Z. Y. (1999). Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B. Biochemistry®, 38(12), 3793-3803. https://doi.org/10.1021/bi9813781

Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B. / Taing, Meng; Keng, Yen Fang; Shen, Kui; Wu, Li; Lawrence, David S.; Zhang, Zhong Yin.

In: Biochemistry®, Vol. 38, No. 12, 23.03.1999, p. 3793-3803.

Research output: Contribution to journalArticle

Taing, M, Keng, YF, Shen, K, Wu, L, Lawrence, DS & Zhang, ZY 1999, 'Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B', Biochemistry®, vol. 38, no. 12, pp. 3793-3803. https://doi.org/10.1021/bi9813781
Taing M, Keng YF, Shen K, Wu L, Lawrence DS, Zhang ZY. Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B. Biochemistry®. 1999 Mar 23;38(12):3793-3803. https://doi.org/10.1021/bi9813781
Taing, Meng ; Keng, Yen Fang ; Shen, Kui ; Wu, Li ; Lawrence, David S. ; Zhang, Zhong Yin. / Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B. In: Biochemistry®. 1999 ; Vol. 38, No. 12. pp. 3793-3803.
@article{61a9734ae34b458d845619321b5e61f1,
title = "Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B",
abstract = "Several protein tyrosine phosphatases (PTPases) have been implicated as regulatory agents in the insulin-stimulated signal transduction pathway, including PTP1B, PTPα, and LAR. Furthermore, since all three enzymes are suggested to serve as negative regulators of insulin signaling, one or more may play a pivotal role in the pathogenesis of insulin resistance. We report herein the acquisition of highly selective PTP1B-targeted inhibitors. We recently demonstrated that PTP1B contains two proximal aromatic phosphate binding sites [Puius, Y. A., Zhao, Y., Sullivan, M., Lawrence, D. S., Almo S. C., and Zhang, Z. Y. (1997) Proc. Natl. Acad. Sci. U.S.A. 94, 13420-5], and we have now employed this structural feature to design and synthesize an array of bis(aryldifluorophosphonates). Not only do the lead compounds serve as potent inhibitors of PTP1B but, in addition, several exhibit selectivities for PTP1B versus PTPα, LAR, and VHR that are greater than 2 orders in magnitude.",
author = "Meng Taing and Keng, {Yen Fang} and Kui Shen and Li Wu and Lawrence, {David S.} and Zhang, {Zhong Yin}",
year = "1999",
month = "3",
day = "23",
doi = "10.1021/bi9813781",
language = "English (US)",
volume = "38",
pages = "3793--3803",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "12",

}

TY - JOUR

T1 - Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B

AU - Taing, Meng

AU - Keng, Yen Fang

AU - Shen, Kui

AU - Wu, Li

AU - Lawrence, David S.

AU - Zhang, Zhong Yin

PY - 1999/3/23

Y1 - 1999/3/23

N2 - Several protein tyrosine phosphatases (PTPases) have been implicated as regulatory agents in the insulin-stimulated signal transduction pathway, including PTP1B, PTPα, and LAR. Furthermore, since all three enzymes are suggested to serve as negative regulators of insulin signaling, one or more may play a pivotal role in the pathogenesis of insulin resistance. We report herein the acquisition of highly selective PTP1B-targeted inhibitors. We recently demonstrated that PTP1B contains two proximal aromatic phosphate binding sites [Puius, Y. A., Zhao, Y., Sullivan, M., Lawrence, D. S., Almo S. C., and Zhang, Z. Y. (1997) Proc. Natl. Acad. Sci. U.S.A. 94, 13420-5], and we have now employed this structural feature to design and synthesize an array of bis(aryldifluorophosphonates). Not only do the lead compounds serve as potent inhibitors of PTP1B but, in addition, several exhibit selectivities for PTP1B versus PTPα, LAR, and VHR that are greater than 2 orders in magnitude.

AB - Several protein tyrosine phosphatases (PTPases) have been implicated as regulatory agents in the insulin-stimulated signal transduction pathway, including PTP1B, PTPα, and LAR. Furthermore, since all three enzymes are suggested to serve as negative regulators of insulin signaling, one or more may play a pivotal role in the pathogenesis of insulin resistance. We report herein the acquisition of highly selective PTP1B-targeted inhibitors. We recently demonstrated that PTP1B contains two proximal aromatic phosphate binding sites [Puius, Y. A., Zhao, Y., Sullivan, M., Lawrence, D. S., Almo S. C., and Zhang, Z. Y. (1997) Proc. Natl. Acad. Sci. U.S.A. 94, 13420-5], and we have now employed this structural feature to design and synthesize an array of bis(aryldifluorophosphonates). Not only do the lead compounds serve as potent inhibitors of PTP1B but, in addition, several exhibit selectivities for PTP1B versus PTPα, LAR, and VHR that are greater than 2 orders in magnitude.

UR - http://www.scopus.com/inward/record.url?scp=0033596855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033596855&partnerID=8YFLogxK

U2 - 10.1021/bi9813781

DO - 10.1021/bi9813781

M3 - Article

C2 - 10090769

AN - SCOPUS:0033596855

VL - 38

SP - 3793

EP - 3803

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 12

ER -